Sierra Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.99M Buy
8,157
+13
+0.2% +$3.03K 0.22% 87
2025
Q4
$1.69M Buy
8,144
+41
+0.5% +$8.11K 0.18% 93
2025
Q3
$1.5M Hold
8,103
0.16% 104
2025
Q2
$1.24M Hold
8,103
0.14% 111
2025
Q1
$1.34M Buy
8,103
+506
+7% +$79.2K 0.16% 103
2024
Q4
$1.1M Sell
7,597
-507
-6% -$78.6K 0.13% 112
2024
Q3
$1.31M Hold
8,104
0.16% 106
2024
Q2
$1.18M Hold
8,104
0.16% 105
2024
Q1
$1.28M Buy
8,104
+59
+0.7% +$9.39K 0.17% 106
2023
Q4
$1.26M Sell
8,045
-154
-2% -$23.6K 0.19% 102
2023
Q3
$1.28M Hold
8,199
0.21% 97
2023
Q2
$1.36M Hold
8,199
0.21% 94
2023
Q1
$1.27M Sell
8,199
-1,837
-18% -$297K 0.21% 94
2022
Q4
$1.77M Buy
10,036
+61
+0.6% +$10.5K 0.3% 67
2022
Q3
$1.63M Sell
9,975
-36
-0.4% -$6.09K 0.3% 67
2022
Q2
$1.78M Sell
10,011
-7
-0.1% -$1.25K 0.32% 70
2022
Q1
$1.77M Sell
10,018
-88
-0.9% -$15K 0.28% 78
2021
Q4
$1.73M Buy
10,106
+180
+2% +$29.5K 0.26% 84
2021
Q3
$1.6M Sell
9,926
-521
-5% -$88.9K 0.27% 87
2021
Q2
$1.72M Hold
10,447
0.32% 79
2021
Q1
$1.72M Buy
+10,447
New +$1.69M 0.32% 79

Other funds holding JNJ

Sierra Capital's JNJ Position: Q1 2026 in Review

Sierra Capital increased its Johnson & Johnson (JNJ) stake by 0.16% in Q1 2026, buying an estimated $3.03K and bringing the position to 8,157 shares worth $1.99M. The position accounts for 0.22% of the portfolio, ranked #87.

Sierra Capital first reported a position in JNJ in Q1 2021 and has held it in 21 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sierra Capital held 8,157 shares of Johnson & Johnson worth $1.99M as of Q1 2026.
  • Sierra Capital bought 13 Johnson & Johnson shares in Q1 2026, an estimated $3.03K.
  • Johnson & Johnson made up 0.22% of Sierra Capital's portfolio in Q1 2026, its #87 holding.
  • Sierra Capital first reported a position in Johnson & Johnson in Q1 2021 and has held it in 21 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sierra Capital's 13F filing for Q1 2026, filed 15 May 2026.